MedPath

Bausch & Lomb Incorporated

🇺🇸United States
Ownership
-
Established
1992-10-08
Employees
-
Market Cap
-
Website

Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1

Not Applicable
Completed
Conditions
Habitual Soft Contact Lens Use
Interventions
Device: Kalifon A
Device: Precision1
Device: Dailies Total1
First Posted Date
2021-04-12
Last Posted Date
2021-07-22
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
10
Registration Number
NCT04840563
Locations
🇺🇸

Bausch Site 001, Rochester, New York, United States

Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment

Not Applicable
Completed
Conditions
Ametropia
Interventions
Procedure: Standard Photorefractive keratectomy (PRK)
Procedure: Transepithelial Photorefractive keratectomy (tPRK) without laser polishing
Procedure: Transepithelial Photorefractive keratectomy (tPRK) with laser polishing
First Posted Date
2021-01-06
Last Posted Date
2022-10-07
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
39
Registration Number
NCT04698174
Locations
🇵🇭

Asian Eye Institute, Makati City, Philippines

Safety and Efficacy of Different Add Powers With a New Presbyopic Lasik Treatment Algorithm

Not Applicable
Completed
Conditions
Ametropia
Interventions
Procedure: SUPRACOR Regular
Procedure: SUPRACOR Strong
First Posted Date
2020-11-05
Last Posted Date
2024-03-01
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
60
Registration Number
NCT04617080
Locations
🇵🇭

Asian Eye Institute, Makati City, Philippines

Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)

Phase 3
Completed
Conditions
Dry Eye Disease
Interventions
Drug: NOV03
Drug: Saline Solution
First Posted Date
2020-09-28
Last Posted Date
2024-08-19
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
620
Registration Number
NCT04567329
Locations
🇺🇸

Bausch Site 226, Murrieta, California, United States

🇺🇸

Bausch Site 202, Garden Grove, California, United States

🇺🇸

Bausch Site 220, Norfolk, Virginia, United States

and more 32 locations

Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses

Not Applicable
Completed
Conditions
Habitual Soft Contact Lens Use
Interventions
Device: kalifilcon A lenses
Device: Dalies Total 1
Device: Precision 1
Device: Biotrue ONEday
First Posted Date
2020-09-18
Last Posted Date
2021-11-08
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
10
Registration Number
NCT04555031
Locations
🇺🇸

Bausch and Lomb Site 01, Rochester, New York, United States

Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: enVista MX60EFH trifocal intraocular lenses (IOLs)
Device: enVista MX60E monofocal intraocular lenses (IOLs)
First Posted Date
2020-01-13
Last Posted Date
2024-10-10
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
165
Registration Number
NCT04224155
Locations
🇨🇦

Bausch Site 108, Vaughan, Ontario, Canada

🇨🇦

Bausch Site 104, Montréal, Quebec, Canada

🇨🇦

Bausch Site 106, Calgary, Alberta, Canada

and more 6 locations

A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: CVisc50 OVD
Device: ProVisc OVD
Procedure: Cataract Surgery
First Posted Date
2019-12-10
Last Posted Date
2024-05-28
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
390
Registration Number
NCT04192630
Locations
🇺🇸

Bausch Site 011, Newport Beach, California, United States

🇺🇸

Bausch Site 004, Torrance, California, United States

🇺🇸

Bausch Site 014, Goodlettsville, Tennessee, United States

and more 19 locations

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Not Applicable
Completed
Conditions
Contact Lens Wear
Interventions
Device: BL-300-PFM04
Device: OPTI-FREE
First Posted Date
2019-11-25
Last Posted Date
2024-07-10
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
369
Registration Number
NCT04175340
Locations
🇺🇸

Bausch Site 104, Decatur, Georgia, United States

🇺🇸

Bausch Site 108, San Francisco, California, United States

🇺🇸

Bausch Site 106, Sarasota, Florida, United States

and more 12 locations

A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens

Not Applicable
Completed
Conditions
Contact Lens Wear
Interventions
Device: Kalifilcon A Daily Disposable Contact Lenses
Device: Biotrue ONEday Daily Disposable Contact Lenses
First Posted Date
2019-11-08
Last Posted Date
2020-11-19
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
252
Registration Number
NCT04158466
Locations
🇺🇸

Bausch Site 16, Honolulu, Hawaii, United States

🇺🇸

Bausch Site 1, Saint Louis, Missouri, United States

🇺🇸

Bausch Site 11, Bloomington, Minnesota, United States

and more 13 locations

Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

Phase 3
Completed
Conditions
Dry Eye Disease (DED)
Interventions
First Posted Date
2019-10-25
Last Posted Date
2024-03-04
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
256
Registration Number
NCT04140227
Locations
🇺🇸

Bausch Site 101, Newport Beach, California, United States

🇺🇸

Bausch Site 123, Torrance, California, United States

🇺🇸

Bausch Site 103, Torrance, California, United States

and more 25 locations
© Copyright 2025. All Rights Reserved by MedPath